{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:41:01Z","timestamp":1790095261817,"version":"4.0.1"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11914-016-0315-2","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T07:40:08Z","timestamp":1464853208000},"page":"151-158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["The Bone Microenvironment: a Fertile Soil for Tumor Growth"],"prefix":"10.1007","volume":"14","author":[{"given":"Denise","family":"Buenrostro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick L.","family":"Mulcrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Sterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,2]]},"reference":[{"issue":"2","key":"315_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69\u201390.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"315_CR2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00666208","volume":"32","author":"T Yoneda","year":"1994","unstructured":"Yoneda T, Sasaki A, Mundy GR. Osteolytic bone metastasis in breast cancer. Breast Cancer Res Treat. 1994;32(1):73\u201384.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"315_CR3","first-page":"18","volume":"19","author":"TA Guise","year":"1998","unstructured":"Guise TA, Mundy GR. Cancer and bone. Endocr Rev. 1998;19(1):18\u201354.","journal-title":"Endocr Rev"},{"issue":"3","key":"315_CR4","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1158\/0008-5472.CAN-10-2993","volume":"71","author":"RW Johnson","year":"2011","unstructured":"Johnson RW et al. TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical hedgehog signaling. Cancer Res. 2011;71(3):822\u201331.","journal-title":"Cancer Res"},{"issue":"8","key":"315_CR5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","volume":"2","author":"GR Mundy","year":"2002","unstructured":"Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002;2(8):584\u201393.","journal-title":"Nat Rev Cancer"},{"issue":"Suppl 3","key":"315_CR6","doi-asserted-by":"crossref","first-page":"iii 124-37","DOI":"10.1093\/annonc\/mdu103","volume":"25","author":"R Coleman","year":"2014","unstructured":"Coleman R et al. Bone health in cancer patients: ESMO clinical practice guidelines. Ann Oncol. 2014;25 Suppl 3:iii 124-37.","journal-title":"Ann Oncol"},{"issue":"9","key":"315_CR7","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S1470-2045(14)70302-X","volume":"15","author":"R Coleman","year":"2014","unstructured":"Coleman R et al. Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01\/04) randomised open-label phase 3 trial. Lancet Oncol. 2014;15(9):997\u20131006.","journal-title":"Lancet Oncol"},{"issue":"6","key":"315_CR8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/bcr2769","volume":"12","author":"I Holen","year":"2010","unstructured":"Holen I, Coleman RE. Anti-tumour activity of bisphosphonates in preclinical models of breast cancer. Breast Cancer Res. 2010;12(6):214.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"315_CR9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","volume":"49","author":"RG Russell","year":"2011","unstructured":"Russell RG. Bisphosphonates: the first 40\u00a0years. Bone. 2011;49(1):2\u201319.","journal-title":"Bone"},{"issue":"4","key":"315_CR10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","volume":"48","author":"R Baron","year":"2011","unstructured":"Baron R, Ferrari S, Russell RG. Denosumab and bisphosphonates: different mechanisms of action and effects. Bone. 2011;48(4):677\u201392.","journal-title":"Bone"},{"issue":"7","key":"315_CR11","doi-asserted-by":"crossref","first-page":"e6361","DOI":"10.1371\/journal.pone.0006361","volume":"4","author":"A Kostic","year":"2009","unstructured":"Kostic A, Lynch CD, Sheetz MP. Differential matrix rigidity response in breast cancer cell lines correlates with the tissue tropism. PLoS One. 2009;4(7):e6361.","journal-title":"PLoS One"},{"issue":"49","key":"315_CR12","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1038\/onc.2009.299","volume":"28","author":"PP Provenzano","year":"2009","unstructured":"Provenzano PP et al. Matrix density-induced mechanoregulation of breast cell phenotype, signaling, and gene expression through a FAK-ERK linkage. Oncogene. 2009;28(49):4326\u201343.","journal-title":"Oncogene"},{"key":"315_CR13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.biomaterials.2015.06.026","volume":"64","author":"JM Page","year":"2015","unstructured":"Page JM et al. Matrix rigidity regulates the transition of tumor cells to a bone-destructive phenotype through integrin beta3 and TGF-beta receptor type II. Biomaterials. 2015;64:33\u201344. This paper demonstrated that the rigid mineralized bone matrix can alter gene expression and bone destruction in an integrin beta 3-TGF-\u03b2 dependent manner.","journal-title":"Biomaterials"},{"issue":"11","key":"315_CR14","doi-asserted-by":"crossref","first-page":"e15451","DOI":"10.1371\/journal.pone.0015451","volume":"5","author":"NS Ruppender","year":"2010","unstructured":"Ruppender NS et al. Matrix rigidity induces osteolytic gene expression of metastatic breast cancer cells. PLoS One. 2010;5(11):e15451.","journal-title":"PLoS One"},{"key":"315_CR15","doi-asserted-by":"crossref","unstructured":"Johnson RW et al. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer. Clin Exp Metastasis. 2014.","DOI":"10.1007\/s10585-014-9682-1"},{"key":"315_CR16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.biomaterials.2015.03.010","volume":"54","author":"R Guo","year":"2015","unstructured":"Guo R et al. A transient cell-shielding method for viable MSC delivery within hydrophobic scaffolds polymerized in situ. Biomaterials. 2015;54:21\u201333.","journal-title":"Biomaterials"},{"issue":"6","key":"315_CR17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc3055","volume":"11","author":"KN Weilbaecher","year":"2011","unstructured":"Weilbaecher KN, Guise TA, McCauley LK. Cancer to bone: a fatal attraction. Nat Rev Cancer. 2011;11(6):411\u201325.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"315_CR18","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI118947","volume":"98","author":"TA Guise","year":"1996","unstructured":"Guise TA et al. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest. 1996;98(7):1544\u20139.","journal-title":"J Clin Invest"},{"issue":"2","key":"315_CR19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ccell.2014.11.017","volume":"27","author":"H Wang","year":"2015","unstructured":"Wang H et al. The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells. Cancer Cell. 2015;27(2):193\u2013210.","journal-title":"Cancer Cell"},{"issue":"4","key":"315_CR20","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1210\/en.2004-1211","volume":"146","author":"A Schneider","year":"2005","unstructured":"Schneider A et al. Bone turnover mediates preferential localization of prostate cancer in the skeleton. Endocrinology. 2005;146(4):1727\u201336.","journal-title":"Endocrinology"},{"issue":"6","key":"315_CR21","first-page":"1832","volume":"62","author":"RS Taichman","year":"2002","unstructured":"Taichman RS et al. Use of the stromal cell-derived factor-1\/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res. 2002;62(6):1832\u20137.","journal-title":"Cancer Res"},{"issue":"4","key":"315_CR22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10555-010-9256-x","volume":"29","author":"X Sun","year":"2010","unstructured":"Sun X et al. CXCL12\/CXCR4\/CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev. 2010;29(4):709\u201322.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"315_CR23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1182\/blood-2006-05-021352","volume":"110","author":"Y Jung","year":"2007","unstructured":"Jung Y et al. Annexin II expressed by osteoblasts and endothelial cells regulates stem cell adhesion, homing, and engraftment following transplantation. Blood. 2007;110(1):82\u201390.","journal-title":"Blood"},{"issue":"5","key":"315_CR24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1596\/neo.111740","volume":"14","author":"Y Jung","year":"2012","unstructured":"Jung Y et al. Prevalence of prostate cancer metastases after intravenous inoculation provides clues into the molecular basis of dormancy in the bone marrow microenvironment. Neoplasia. 2012;14(5):429\u201339.","journal-title":"Neoplasia"},{"issue":"2","key":"315_CR25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.exphem.2010.11.007","volume":"39","author":"Y Jung","year":"2011","unstructured":"Jung Y et al. Annexin 2 is a regulator of SDF-1\/CXCL12 function in the hematopoietic stem cell endosteal niche. Exp Hematol. 2011;39(2):151\u2013166.e1.","journal-title":"Exp Hematol"},{"key":"315_CR26","doi-asserted-by":"publisher","unstructured":"Park, SI et al. Parathyroid hormone-related protein drives a CD11b(+)Gr1(+) cell-mediated positive feedback loop to support prostate cancer growth. Cancer Res, 2013; 73(22), doi: 10.1158\/0008-5472.CAN-12-4692 .","DOI":"10.1158\/0008-5472.CAN-12-4692"},{"issue":"2","key":"315_CR27","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1210\/endo.143.2.8639","volume":"143","author":"N Akeno","year":"2002","unstructured":"Akeno N et al. Induction of vascular endothelial growth factor by IGF-I in osteoblast-like cells is mediated by the PI3K signaling pathway through the hypoxia-inducible factor-2alpha. Endocrinology. 2002;143(2):420\u20135.","journal-title":"Endocrinology"},{"key":"315_CR28","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/ncomms2313","volume":"3","author":"JM Kim","year":"2012","unstructured":"Kim JM et al. DJ-1 promotes angiogenesis and osteogenesis by activating FGF receptor-1 signaling. Nat Commun. 2012;3:1296.","journal-title":"Nat Commun"},{"issue":"4","key":"315_CR29","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/01.bor.0000231913.32364.32","volume":"18","author":"BF Boyce","year":"2006","unstructured":"Boyce BF, Schwarz EM, Xing L. Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease. Curr Opin Rheumatol. 2006;18(4):427\u201332. doi: 10.1097\/01.bor.0000231913.32364.32 .","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"315_CR30","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","volume":"8","author":"DA Glass 2nd","year":"2005","unstructured":"Glass 2nd DA et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell. 2005;8(5):751\u201364.","journal-title":"Dev Cell"},{"issue":"16","key":"315_CR31","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman GD. Mechanisms of bone metastasis. N Engl J Med. 2004;350(16):1655\u201364.","journal-title":"N Engl J Med"},{"issue":"7","key":"315_CR32","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1242\/jcs.063032","volume":"124","author":"JC Crockett","year":"2011","unstructured":"Crockett JC et al. Bone remodelling at a glance. J Cell Sci. 2011;124(7):991\u20138.","journal-title":"J Cell Sci"},{"issue":"35","key":"315_CR33","doi-asserted-by":"crossref","first-page":"14062","DOI":"10.1073\/pnas.0705203104","volume":"104","author":"AC Hirbe","year":"2007","unstructured":"Hirbe AC et al. Disruption of CXCR4 enhances osteoclastogenesis and tumor growth in bone. Proc Natl Acad Sci U S A. 2007;104(35):14062\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"315_CR34","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/onc.2014.113","volume":"34","author":"JZ Zhou","year":"2015","unstructured":"Zhou JZ et al. Differential impact of adenosine nucleotides released by osteocytes on breast cancer growth and bone metastasis. Oncogene. 2015;34(14):1831\u201342.","journal-title":"Oncogene"},{"issue":"11","key":"315_CR35","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1158\/0008-5472.CAN-14-2493","volume":"75","author":"JL Sottnik","year":"2015","unstructured":"Sottnik JL et al. Tumor-induced pressure in the bone microenvironment causes osteocytes to promote the growth of prostate cancer bone metastases. Cancer Res. 2015;75(11):2151\u20138. This paper presents data identifying the contribution of physical forces to tumor cell growth and that osteocytes play an important role as mediators in the bone metastatic niche.","journal-title":"Cancer Res"},{"issue":"5","key":"315_CR36","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1158\/0008-5472.CAN-15-1703","volume":"76","author":"J Delgado-Calle","year":"2016","unstructured":"Delgado-Calle J et al. Bidirectional notch signaling and osteocyte-derived factors in the bone marrow microenvironment promote tumor cell proliferation and bone destruction in multiple myeloma. Cancer Res. 2016;76(5):1089\u2013100.","journal-title":"Cancer Res"},{"key":"315_CR37","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fonc.2014.00062","volume":"4","author":"M Augsten","year":"2014","unstructured":"Augsten M. Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment. Front Oncol. 2014;4:62.","journal-title":"Front Oncol"},{"issue":"50","key":"315_CR38","doi-asserted-by":"crossref","first-page":"21677","DOI":"10.1073\/pnas.1016234107","volume":"107","author":"DG Duda","year":"2010","unstructured":"Duda DG et al. Malignant cells facilitate lung metastasis by bringing their own soil. Proc Natl Acad Sci U S A. 2010;107(50):21677\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"315_CR39","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/ncb2756","volume":"15","author":"F Calvo","year":"2013","unstructured":"Calvo F et al. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat Cell Biol. 2013;15(6):637\u201346.","journal-title":"Nat Cell Biol"},{"key":"315_CR40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semcancer.2013.12.005","volume":"25","author":"J Harper","year":"2014","unstructured":"Harper J, Sainson RC. Regulation of the anti-tumour immune response by cancer-associated fibroblasts. Semin Cancer Biol. 2014;25:69\u201377.","journal-title":"Semin Cancer Biol"},{"issue":"6005","key":"315_CR41","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.1195300","volume":"330","author":"M Kraman","year":"2010","unstructured":"Kraman M et al. Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-\u03b1. Science. 2010;330(6005):827\u201330.","journal-title":"Science"},{"issue":"2","key":"315_CR42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10555-010-9222-7","volume":"29","author":"SA Bergfeld","year":"2010","unstructured":"Bergfeld SA, DeClerck YA. Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev. 2010;29(2):249\u201361.","journal-title":"Cancer Metastasis Rev"},{"issue":"2","key":"315_CR43","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccr.2011.01.020","volume":"19","author":"M Quante","year":"2011","unstructured":"Quante M et al. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell. 2011;19(2):257\u201372.","journal-title":"Cancer Cell"},{"issue":"4","key":"315_CR44","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1158\/1535-7163.MCT-13-0400","volume":"13","author":"SA Bergfeld","year":"2014","unstructured":"Bergfeld SA, Blavier L, DeClerck YA. Bone marrow-derived mesenchymal stromal cells promote survival and drug resistance in tumor cells. Mol Cancer Ther. 2014;13(4):962\u201375.","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"315_CR45","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ijc.2910570319","volume":"57","author":"HC Wu","year":"1994","unstructured":"Wu HC et al. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. Int J Cancer. 1994;57(3):406\u201312.","journal-title":"Int J Cancer"},{"issue":"4","key":"315_CR46","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1158\/1541-7786.MCR-11-0506","volume":"10","author":"X Li","year":"2012","unstructured":"Li X et al. Loss of TGF-beta responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic\/osteolytic bone lesions. Mol Cancer Res. 2012;10(4):494\u2013503.","journal-title":"Mol Cancer Res"},{"issue":"4","key":"315_CR47","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.bbrc.2015.02.013","volume":"458","author":"R Nakamura","year":"2015","unstructured":"Nakamura R et al. Transforming growth factor-beta synthesized by stromal cells and cancer cells participates in bone resorption induced by oral squamous cell carcinoma. Biochem Biophys Res Commun. 2015;458(4):777\u201382.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"315_CR48","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nri2528","volume":"9","author":"JW Pollard","year":"2009","unstructured":"Pollard JW. Trophic macrophages in development and disease. Nat Rev Immunol. 2009;9(4):259\u201370.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"315_CR49","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1158\/0008-5472.CAN-05-4005","volume":"66","author":"CE Lewis","year":"2006","unstructured":"Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006;66(2):605\u201312.","journal-title":"Cancer Res"},{"issue":"2","key":"315_CR50","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2353\/ajpath.2010.090622","volume":"176","author":"L Deng","year":"2010","unstructured":"Deng L et al. A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis. Am J Pathol. 2010;176(2):952\u201367.","journal-title":"Am J Pathol"},{"issue":"3","key":"315_CR51","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1189\/jlb.1107762","volume":"84","author":"JW Pollard","year":"2008","unstructured":"Pollard JW. Macrophages define the invasive microenvironment in breast cancer. J Leukoc Biol. 2008;84(3):623\u201330.","journal-title":"J Leukoc Biol"},{"issue":"6917","key":"315_CR52","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860\u20137.","journal-title":"Nature"},{"issue":"5","key":"315_CR53","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1182\/blood-2005-01-0428","volume":"107","author":"SK Biswas","year":"2006","unstructured":"Biswas SK et al. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3\/STAT1 activation). Blood. 2006;107(5):2112\u201322.","journal-title":"Blood"},{"issue":"1","key":"315_CR54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141(1):39\u201351.","journal-title":"Cell"},{"issue":"2","key":"315_CR55","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.4049\/jimmunol.181.2.1232","volume":"181","author":"MK Chang","year":"2008","unstructured":"Chang MK et al. Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. J Immunol. 2008;181(2):1232\u201344.","journal-title":"J Immunol"},{"issue":"23","key":"315_CR56","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1182\/blood-2009-11-253534","volume":"116","author":"IG Winkler","year":"2010","unstructured":"Winkler IG et al. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood. 2010;116(23):4815\u201328.","journal-title":"Blood"},{"issue":"7","key":"315_CR57","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/jbmr.354","volume":"26","author":"KA Alexander","year":"2011","unstructured":"Alexander KA et al. Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. J Bone Miner Res. 2011;26(7):1517\u201332.","journal-title":"J Bone Miner Res"},{"key":"315_CR58","doi-asserted-by":"crossref","first-page":"875305","DOI":"10.1155\/2014\/875305","volume":"2014","author":"D Buenrostro","year":"2014","unstructured":"Buenrostro D, Park SI, Sterling JA. Dissecting the role of bone marrow stromal cells on bone metastases. Biomed Res Int. 2014;2014:875305.","journal-title":"Biomed Res Int"},{"issue":"9","key":"315_CR59","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1172\/JCI80005","volume":"125","author":"D Marvel","year":"2015","unstructured":"Marvel D, Gabrilovich DI. Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. J Clin Invest. 2015;125(9):3356\u201364. This paper reviews controversial issues in myeloid-derived suppressor cell biology, including their role in cancer progression and metastasis. This review also emphasis how these cells may be used both as prognostic factors and as therapeutic targets.","journal-title":"J Clin Invest"},{"issue":"8","key":"315_CR60","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","volume":"181","author":"JI Youn","year":"2008","unstructured":"Youn JI et al. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol. 2008;181(8):5791\u2013802.","journal-title":"J Immunol"},{"issue":"8","key":"315_CR61","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1182\/blood-2007-07-099226","volume":"111","author":"K Movahedi","year":"2008","unstructured":"Movahedi K et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood. 2008;111(8):4233\u201344.","journal-title":"Blood"},{"issue":"2","key":"315_CR62","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/0008-5472.CAN-05-1299","volume":"66","author":"B Huang","year":"2006","unstructured":"Huang B et al. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 2006;66(2):1123\u201331.","journal-title":"Cancer Res"},{"issue":"12","key":"315_CR63","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1002\/eji.201041037","volume":"40","author":"M Elkabets","year":"2010","unstructured":"Elkabets M et al. IL-1beta regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function. Eur J Immunol. 2010;40(12):3347\u201357.","journal-title":"Eur J Immunol"},{"issue":"1","key":"315_CR64","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/0008-5472.CAN-09-2587","volume":"70","author":"MK Srivastava","year":"2010","unstructured":"Srivastava MK et al. Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res. 2010;70(1):68\u201377.","journal-title":"Cancer Res"},{"issue":"2","key":"315_CR65","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/imm.12036","volume":"138","author":"D Lindau","year":"2013","unstructured":"Lindau D et al. The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology. 2013;138(2):105\u201315.","journal-title":"Immunology"},{"issue":"22","key":"315_CR66","doi-asserted-by":"crossref","first-page":"6574","DOI":"10.1158\/0008-5472.CAN-12-4692","volume":"73","author":"SI Park","year":"2013","unstructured":"Park SI et al. Parathyroid hormone-related protein drives a CD11b+Gr1+ cell-mediated positive feedback loop to support prostate cancer growth. Cancer Res. 2013;73(22):6574\u201383.","journal-title":"Cancer Res"},{"issue":"9","key":"315_CR67","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.4161\/onci.21990","volume":"1","author":"S Danilin","year":"2012","unstructured":"Danilin S et al. Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction. Oncoimmunology. 2012;1(9):1484\u201394.","journal-title":"Oncoimmunology"},{"issue":"2","key":"315_CR68","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1158\/0008-5472.CAN-12-2202","volume":"73","author":"A Sawant","year":"2013","unstructured":"Sawant A et al. Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer. Cancer Res. 2013;73(2):672\u201382. This paper identified myeloid-derived suppressor cells as a novel osteoclast progenitor that had the potential to stimulate bone metastasis during cancer progression.","journal-title":"Cancer Res"},{"issue":"4","key":"315_CR69","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nri3174","volume":"12","author":"E Vivier","year":"2012","unstructured":"Vivier E et al. Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol. 2012;12(4):239\u201352.","journal-title":"Nat Rev Immunol"},{"issue":"6852","key":"315_CR70","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/35093109","volume":"413","author":"A Diefenbach","year":"2001","unstructured":"Diefenbach A et al. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature. 2001;413(6852):165\u201371.","journal-title":"Nature"},{"issue":"10","key":"315_CR71","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1172\/JCI69369","volume":"123","author":"G Liu","year":"2013","unstructured":"Liu G et al. Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis. J Clin Invest. 2013;123(10):4410\u201322.","journal-title":"J Clin Invest"},{"issue":"7550","key":"315_CR72","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nature14388","volume":"521","author":"L Zitvogel","year":"2015","unstructured":"Zitvogel L, Kroemer G. Cancer: antibodies regulate antitumour immunity. Nature. 2015;521(7550):35\u20137.","journal-title":"Nature"},{"issue":"5","key":"315_CR73","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","volume":"8","author":"DA Thomas","year":"2005","unstructured":"Thomas DA, Massague J. TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell. 2005;8(5):369\u201380.","journal-title":"Cancer Cell"},{"issue":"5","key":"315_CR74","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.immuni.2009.04.010","volume":"30","author":"EM Shevach","year":"2009","unstructured":"Shevach EM. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity. 2009;30(5):636\u201345.","journal-title":"Immunity"},{"issue":"6585","key":"315_CR75","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/381751a0","volume":"381","author":"K Rajewsky","year":"1996","unstructured":"Rajewsky K. Clonal selection and learning in the antibody system. Nature. 1996;381(6585):751\u20138.","journal-title":"Nature"},{"issue":"4","key":"315_CR76","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.it.2012.10.007","volume":"34","author":"F Balkwill","year":"2013","unstructured":"Balkwill F, Montfort A, Capasso M. B regulatory cells in cancer. Trends Immunol. 2013;34(4):169\u201373.","journal-title":"Trends Immunol"},{"issue":"14","key":"315_CR77","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1158\/0008-5472.CAN-10-3922","volume":"71","author":"K Zhang","year":"2011","unstructured":"Zhang K et al. CD8+ T cells regulate bone tumor burden independent of osteoclast resorption. Cancer Res. 2011;71(14):4799\u2013808.","journal-title":"Cancer Res"},{"issue":"7","key":"315_CR78","doi-asserted-by":"crossref","first-page":"e68171","DOI":"10.1371\/journal.pone.0068171","volume":"8","author":"AC Monteiro","year":"2013","unstructured":"Monteiro AC et al. T cells induce pre-metastatic osteolytic disease and help bone metastases establishment in a mouse model of metastatic breast cancer. PLoS One. 2013;8(7):e68171.","journal-title":"PLoS One"},{"issue":"10","key":"315_CR79","doi-asserted-by":"crossref","first-page":"797","DOI":"10.18632\/oncotarget.343","volume":"2","author":"E Pasquier","year":"2011","unstructured":"Pasquier E et al. Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment. Oncotarget. 2011;2(10):797\u2013809.","journal-title":"Oncotarget"},{"key":"315_CR80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1747-1028-8-1","volume":"8","author":"Y Ji","year":"2013","unstructured":"Ji Y et al. The role of \u03b2-adrenergic receptor signaling in the proliferation of hemangioma-derived endothelial cells. Cell Div. 2013;8:1\u20131.","journal-title":"Cell Div"},{"issue":"8","key":"315_CR81","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm1447","volume":"12","author":"PH Thaker","year":"2006","unstructured":"Thaker PH et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 2006;12(8):939\u201344.","journal-title":"Nat Med"},{"issue":"3","key":"315_CR82","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.semcancer.2007.12.005","volume":"18","author":"PH Thaker","year":"2008","unstructured":"Thaker PH, Sood AK. The neuroendocrine impact of chronic stress on cancer. Semin Cancer Biol. 2008;18(3):164\u201370.","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"315_CR83","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/ncponc1134","volume":"5","author":"Y Chida","year":"2008","unstructured":"Chida Y et al. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol. 2008;5(8):466\u201375.","journal-title":"Nat Clin Pract Oncol"},{"issue":"3","key":"315_CR84","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jpsychores.2007.05.012","volume":"63","author":"O Palesh","year":"2007","unstructured":"Palesh O et al. Stress history and breast cancer recurrence. J Psychosom Res. 2007;63(3):233\u20139.","journal-title":"J Psychosom Res"},{"issue":"19","key":"315_CR85","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1200\/JCO.2010.33.4441","volume":"29","author":"A Melhem-Bertrandt","year":"2011","unstructured":"Melhem-Bertrandt A et al. Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J Clin Oncol. 2011;29(19):2645\u201352.","journal-title":"J Clin Oncol"},{"issue":"7032","key":"315_CR86","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature03398","volume":"434","author":"F Elefteriou","year":"2005","unstructured":"Elefteriou F et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature. 2005;434(7032):514\u201320.","journal-title":"Nature"},{"issue":"7","key":"315_CR87","doi-asserted-by":"crossref","first-page":"e1001363","DOI":"10.1371\/journal.pbio.1001363","volume":"10","author":"JP Campbell","year":"2012","unstructured":"Campbell JP et al. Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice. PLoS Biol. 2012;10(7):e1001363.","journal-title":"PLoS Biol"},{"issue":"8","key":"315_CR88","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00520-008-0418-0","volume":"16","author":"L Costa","year":"2008","unstructured":"Costa L et al. Impact of skeletal complications on patients\u2019 quality of life, mobility, and functional independence. Support Care Cancer. 2008;16(8):879\u201389.","journal-title":"Support Care Cancer"},{"issue":"S3","key":"315_CR89","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/cncr.11132","volume":"97","author":"S-M K\u00e4k\u00f6nen","year":"2003","unstructured":"K\u00e4k\u00f6nen S-M, Mundy GR. Mechanisms of osteolytic bone metastases in breast carcinoma. Cancer. 2003;97(S3):834\u20139.","journal-title":"Cancer"},{"key":"315_CR90","doi-asserted-by":"crossref","unstructured":"Clohisy DR and PW Mantyh. Bone cancer pain. Clin Orthop Relat Res, 2003, (415 Suppl): 279-88.","DOI":"10.1097\/01.blo.0000093059.96273.56"},{"issue":"20","key":"315_CR91","doi-asserted-by":"crossref","first-page":"9426","DOI":"10.1158\/0008-5472.CAN-05-0826","volume":"65","author":"KG Halvorson","year":"2005","unstructured":"Halvorson KG et al. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone. Cancer Res. 2005;65(20):9426\u201335.","journal-title":"Cancer Res"},{"key":"315_CR92","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neuroscience.2015.02.011","volume":"291","author":"S Falk","year":"2015","unstructured":"Falk S et al. P2X7 receptor-mediated analgesia in cancer-induced bone pain. Neuroscience. 2015;291:93\u2013105.","journal-title":"Neuroscience"},{"issue":"1","key":"315_CR93","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pain.2013.08.030","volume":"155","author":"RG Ungard","year":"2014","unstructured":"Ungard RG, Seidlitz EP, Singh G. Inhibition of breast cancer-cell glutamate release with sulfasalazine limits cancer-induced bone pain. Pain. 2014;155(1):28\u201336.","journal-title":"Pain"},{"issue":"9810","key":"315_CR94","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(11)61226-9","volume":"379","author":"MR Smith","year":"2012","unstructured":"Smith MR et al. Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial. Lancet. 2012;379(9810):39\u201346.","journal-title":"Lancet"},{"issue":"20","key":"315_CR95","doi-asserted-by":"crossref","first-page":"9894","DOI":"10.1158\/0008-5472.CAN-06-3940","volume":"67","author":"C Gall Le","year":"2007","unstructured":"Le Gall C et al. A cathepsin K inhibitor reduces breast cancer induced osteolysis and skeletal tumor burden. Cancer Res. 2007;67(20):9894\u2013902.","journal-title":"Cancer Res"},{"issue":"15","key":"315_CR96","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1158\/1078-0432.CCR-04-2420","volume":"11","author":"M Chavez-Macgregor","year":"2005","unstructured":"Chavez-Macgregor M et al. Angiogenesis in the bone marrow of patients with breast cancer. Clin Cancer Res. 2005;11(15):5396\u2013400.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"315_CR97","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1152\/physiol.00025.2005","volume":"20","author":"H-G Kopp","year":"2005","unstructured":"Kopp H-G et al. The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology. 2005;20(5):349\u201356.","journal-title":"Physiology"},{"issue":"7","key":"315_CR98","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/ncb2767","volume":"15","author":"CM Ghajar","year":"2013","unstructured":"Ghajar CM et al. The perivascular niche regulates breast tumour dormancy. Nat Cell Biol. 2013;15(7):807\u201317. This paper provides evidence for a link between the vascular and tumor dormancy, a subject that had not been well studied.","journal-title":"Nat Cell Biol"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-016-0315-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-016-0315-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-016-0315-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:33:21Z","timestamp":1498318401000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-016-0315-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,2]]},"references-count":98,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["315"],"URL":"https:\/\/doi.org\/10.1007\/s11914-016-0315-2","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,2]]}}}